Spisak Sandor, Chen David, Likasitwatanakul Pornlada, Doan Paul, Li Zhixin, Bala Pratyusha, Vizkeleti Laura, Tisza Viktoria, De Silva Pushpamail, Giannakis Marios, Wolpin Brian, Qi Jun, Sethi Nilay S
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Institute of Enzymology, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
bioRxiv. 2024 Jan 17:2023.06.21.545895. doi: 10.1101/2023.06.21.545895.
Aberrant stem cell-like activity and impaired differentiation are central to the development of colorectal cancer (CRC). To identify functional mediators that regulate these key cellular programs in CRC, we developed an endogenous reporter system by genome-editing human CRC cell lines with knock-in fluorescent reporters at the SOX9 and KRT20 locus to report aberrant stem cell-like activity and differentiation, respectively, and then performed pooled genetic perturbation screens. Constructing a dual reporter system that simultaneously monitored aberrant stem cell-like and differentiation activity in the same CRC cell line improved our signal to noise discrimination. Using a focused-library CRISPR screen targeting 78 epigenetic regulators with 542 sgRNAs, we identified factors that contribute to stem cell-like activity and differentiation in CRC. Perturbation single cell RNA sequencing (Perturb-seq) of validated hits nominated SMARCB1 of the BAF complex (also known as SWI/SNF) as a negative regulator of differentiation across an array of neoplastic colon models. SMARCB1 is a dependency in CRC and required for growth of human CRC models. These studies highlight the utility of a biologically designed endogenous reporter system to uncover novel therapeutic targets for drug development.
异常的干细胞样活性和分化受损是结直肠癌(CRC)发生发展的核心。为了鉴定调控CRC中这些关键细胞程序的功能介质,我们通过对人类CRC细胞系进行基因组编辑,在SOX9和KRT20基因座敲入荧光报告基因,分别报告异常的干细胞样活性和分化,从而开发了一种内源性报告系统,然后进行了混合基因扰动筛选。构建一个在同一CRC细胞系中同时监测异常干细胞样活性和分化活性的双报告系统,提高了我们的信噪比。使用针对78个表观遗传调控因子、含有542个sgRNA的聚焦文库CRISPR筛选,我们鉴定了有助于CRC中干细胞样活性和分化的因子。对已验证的命中靶点进行扰动单细胞RNA测序(Perturb-seq),确定BAF复合物(也称为SWI/SNF)中的SMARCB1是一系列肿瘤性结肠模型中分化的负调控因子。SMARCB1是CRC中的一个依赖性因子,是人类CRC模型生长所必需的。这些研究突出了生物设计的内源性报告系统在发现药物开发新治疗靶点方面的实用性。